A case of inappropriate implantable cardioverter defibrillator therapy induced by T-wave oversensing due to hyperkalemia

A case of inappropriate implantable cardioverter defibrillator therapy induced by T-wave oversensing due to hyperkalemia

There have been reports of hyperkalemia-induced T-wave oversensing in patients with implantable cardioverter defibrillators (ICDs). However, a comparison of T-wave amplitudes and morphologies between the surface 12-lead electrocardiogram (ECG) and ICD electrogram has not been reported. We present th...

Full description

Bibliographic Details
Main Authors:	Kosuke Aoki, Katsunori Okajima, Kunihiko Kiuchi, Kiminobu Yokoi, Jin Teranishi, Akira Shimane
Format:	Article
Language:	English
Published:	Wiley 2015-12-01
Series:	Journal of Arrhythmia
Subjects:	Implantable cardioverter defibrillator Inappropriate ICD therapy Hyperkalemia T-wave oversensing
Online Access:	http://www.sciencedirect.com/science/article/pii/S1880427615000605

Similar Items

OVERSENSING AS A CAUSE OF INAPPROPRIATE IMPLANTABLE CARDIOVERTER- DEFIBRILLATOR THERAPY - CASE REPORT
by: Tomislav Kostić, et al.
Published: (2013-12-01)

Implantable cardioverter-defibrillator oversensing due to electric shock
by: Jurčević Ružica, et al.
Published: (2010-01-01)

Inappropriate Shock Delivered By Implantable Cardioverter Defibrillator - Cardiac Resynchronization Therapy (ICD-CRT) Due To Myopotential Oversensing
by: Hamid Barakpour, et al.
Published: (2009-01-01)

Inappropriate shocks in a patient with a subcutaneous implantable cardioverter-defibrillator
by: Sana M. Al-Khatib, MD, MHS, FHRS, et al.
Published: (2016-11-01)

Two cases of inappropriate implantable cardioverter-defibrillator therapies due to T wave oversensing induced by body twisting
by: Nobuhiro Nishii, MD, et al.
Published: (2017-04-01)

Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator sensed and successfully treated as a result of oversensing
by: Ali A. Sovari, MD, et al.
Published: (2017-02-01)

Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator
by: Sing-Chien Yap, MD, PhD, et al.
Published: (2015-05-01)

T-wave oversensing during left ventricular pacing causing inappropriate defibrillation
by: Joshua Payne, MD, MPH, et al.
Published: (2017-10-01)

Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator
by: Ankur A. Karnik, MD, FHRS, FACC, et al.
Published: (2017-04-01)

A novel screening test for inappropriate shocks due to myopotentials from the subcutaneous implantable cardioverter–defibrillatorKey Findings
by: Yuji Ishida, MD, PhD, et al.
Published: (2020-04-01)

Inappropriate shocks from a subcutaneous implantable cardioverter-defibrillator due to oversensing during periods of rate-related bundle branch block
by: Maria João Sousa, MD, et al.
Published: (2017-02-01)

Postural change-dependent T-wave oversensing resulting in the administration of inappropriate shocks
by: Yukoh Hirai, et al.
Published: (2012-10-01)

Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy
by: Nobuhiro Nishii, et al.
Published: (2021-06-01)

Repeat inappropriate defibrillator discharges following defibrillator implantation. What is the mechanism and treatment?
by: Jeremy W. Docekal, MD, et al.
Published: (2016-09-01)

Oversensing of an unexpected atrial flutter. A new tool to improve detection of supraventricular arrhythmias in subcutaneous implantable cardioverter-defibrillators
by: Luca Santini, MD, PhD, et al.
Published: (2017-06-01)

Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation
by: Omid Kiamanesh, MD, et al.
Published: (2015-07-01)

T wave oversensing in subcutaneous implantable cardioverter defibrillator secondary to hematoma formation: A potential cause of early postimplantation inappropriate shocks
by: Ahmad Halawa, et al.
Published: (2019-02-01)

SMART pass will prevent inappropriate operation of S‐ICD
by: Motomi Tachibana, et al.
Published: (2019-02-01)

Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential oversensing
by: Paola Berne, MD, et al.
Published: (2017-10-01)

Two undesired conditions resulting from T-Wave oversensing in two patients with hypertrophic cardiomyopathy: Inappropriate ICD shocks and pacemaker dysfunction
by: Filiz Kizilirmak, et al.
Published: (2017-01-01)

Clinical and electrocardiographic predictors of T wave oversensing in patients with subcutaneous ICD
by: Mikhael F. El-Chami, MD, et al.
Published: (2016-06-01)

T Wave Safety Margin during the Process of ICD Implantation As a Novel Predictor of T Wave Oversensing
by: Ya-Xun Sun, et al.
Published: (2017-09-01)

The runaway defibrillator…A case of an implantable cardioverter-defibrillator that failed communication and deactivation with a magnet
by: Mahmoud Assaad, MD, et al.
Published: (2016-01-01)

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
by: Tsukasa Kamakura, MD, PhD, et al.
Published: (2016-09-01)

Inappropriate implantable cardioverter-defibrillator shocks in Brugada syndrome: Pattern in primary and secondary prevention
by: Aimé Bonny, et al.
Published: (2017-01-01)

A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change
by: Timothy M. Markman, MD, et al.
Published: (2021-08-01)

Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center
by: Nobuhiro Nishii, MD, et al.
Published: (2017-08-01)

Unexpected inhibition of bradycardia pacing due to oversensing in ICD lead fracture associated with spurious tachyarrhythmia detection and discharges
by: Fani Zagkli, et al.
Published: (2021-05-01)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

Inappropriate subcutaneous implantable cardioverter-defibrillator therapy due to R-wave amplitude variation: Another challenge in device management
by: Syeda A. Batul, MD, et al.
Published: (2017-01-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Impact of a novel algorithm designed to reduce T-wave oversensing with the subcutaneous defibrillator in a patient with type I Brugada electrocardiogram
by: Serge Boveda, MD, et al.
Published: (2018-01-01)

High Incidence of Inappropriate Alarms in Patients with Wearable Cardioverter-Defibrillators: Findings from the Swiss WCD Registry
by: Boldizsar Kovacs, et al.
Published: (2021-08-01)

T-wave oversensing from postural changes: A rare cause of inappropriate shock from a subcutaneous defibrillator
by: Muhammad R. Afzal, MD, et al.
Published: (2017-08-01)

Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
by: Kohei Ishibashi, MD, PhD, et al.
Published: (2017-04-01)

Inappropriate implantable cardioverter-defibrillator shocks in repaired tetralogy of fallot patients: Prevalence and electrophysiological mechanisms
by: Isaac L.Goldenthal, et al.
Published: (2020-06-01)

Twiddler's syndrome: An unusual cause of repeated shocks by implantable cardioverter-defibrillator in an asymptomatic patient
by: Ahmad Jabri, et al.
Published: (2019-01-01)

A Fortuitous Syncope. The pitfalls of Integrated Bipolar Defibrillator Leads
by: Tushar V Salukhe, et al.
Published: (2008-11-01)

Monitoring zone-associated implantable cardioverter defibrillator shock: A case report
by: Hisayasu Matsuzaki, et al.
Published: (2012-08-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)